Therapeutic targets
- Toxin removal
- Preservation of vital functions (vital functions while awake, respiration and circulation).
- Recovery
Therapy recommendations
In addition to symptom-based therapy, specific treatments are required for poisoning (where antidotes/counterpoisons are available):
- Primary toxin removal
- Application of medical charcoal (activated charcoal: see below) – within the first hour after ingestion of a noxious agent that binds to charcoal
- Delayed administration of activated charcoal is indicated for the following drugs: Citalopram, paracetamol, promethazine, quetiapine.
- repetitive administration of activated charcoal is indicated with the following medications:
- Amatoxin, colchicine (marked enterohepatic circulation).
- Carbamazepine, quinine, dapsone, phenobarbital, theophylline.
- Digoxin/digitoxin (marked enterohepatic circulation; if no digitalis antidote available/s. u. Antidota).
- Retarded quetiapine (bezoar-forming drug).
- See below list: “Drugs/toxins with proven or absent adsorption to activated charcoal”.
- Application of medical charcoal (activated charcoal: see below) – within the first hour after ingestion of a noxious agent that binds to charcoal
- Gastric lavage with isotonic saline (if necessary. under intubation (artificial respiration via a breathing tube inserted through the nose), in case of intoxication with potential effects on the CNS) – within the first hour after ingestion of a potentially life-threatening threatening dose of noxious substance (poisons), which is also absorbed extremely protracted (“delayed”), which is also absorbed extremely protractedContraindications: corrosive substances, and long-chain hydrocarbon compounds (eg, gasoline, lamp oils).
- Secondary toxin removal (urinary alkalinization, hemodialysis/detoxification of blood outside the body or hemoperfusion).
- Administration of antidotes/counterpoisons (see below)Note: Unless there is a specific antidote (e.g., amphetamine intoxication), therapy is symptomatic and supportive.
- Continuous monitoring (intensive care unit).
- See also under “Further therapy“.
Agents (main indication) for absorption inhibition/elimination acceleration
Active ingredients | Dosage | Special features |
Activated carbon |
but not more than 50 g Charcoal amount 10 times over the amount of poison |
Optimal if poison intake < 1 hour (poison intake > 1 hour: absorption capacity only 20-60 %)Then Glauber’s salt 15-30 g p.o. (diluted) |
Sodium hydrogen carbonate | Not specified | No longer recommended (activated carbon superior) |
- Mode of action Activated charcoal: absorption reduction based on its large external surface area, which is over 2,000 m 2/g; elimination acceleration of drugs subject to enteropatic circulation (e.g., antiepileptic drugs, theophylline).
- Indications: See below list: “Drugs / toxins with proven or lack of adsorption to activated carbon“.
- Indications for repetitive administration: intoxication with carbamazepine, quinine, dapsone, phenobarbital, theophylline.
- Contraindications:
- Patient clouded in consciousness without adequate swallowing reflexes without securing airway.
- Increased risk of aspiration pneumonia (solvents, surfactants).
- Gastrointestinal burns (e.g., acids, alkalis, iron salts), bleeding, impaired gastrointestinal passage or suspected perforation.
- Ingestion of gasoline/oil or other non-adsorbable substances/toxins.
- Recurrent vomiting
- Administration of activated charcoal against the express will of the patient or child (except in cases of attempted suicide)
- Side effects: Aspiration
- Mode of action sodium bicarbonate: urinary alkalinization.
- Indications: Intoxication with salicylates, barbiturates, dichlorophenoxyacetic acid herbicides.
Drugs / toxins with proven or lack of adsorption to activated carbon.
Drugs that are adsorbed |
|
Plant substances/toxins that are absorbed. |
|
Substances/toxins that are not absorbed or not absorbed sufficiently |
|
Antidota
Active substance (antidote) | Mode of action | Intoxications |
Atropine | Blockade of muscarinic receptors | OrganophosphatesNerve agents (e.g., sarin (methylfluorophosphonic acid isopropyl ester))Muscarinic syndrome caused by crack fungi |
Beclomethasone dipropionate | Sealing of capillary membranes | Flue gasOther pulmonary irritantsIn case of hydrogen cyanide involvement: Sodium thiosulfate, hydroxocobalamin. |
Biperiden | Anticholinergic | Neuroleptic-associated extrapyramidal motor disorders. |
Calcium gluconate | Calcium ions combine with the free fluoride ions (F-) in the body | Hydrofluoric acid (fluorides), oxalic acid (star fruit, rhubarb). |
Calcium trisodium tetate | Complexing agent | Lead, chromium, iron, manganese, zinc salts. |
Deferoxamine | Complexing agent | IronIron overload [see also guideline below: secondary iron overload in patients with congenital anemias, diagnosis and therapy]. |
Diazepam | Benzodiazepine | Chloroquine |
Digitalis antidote | Binds free glycoside (digitalis antibody) | Digitalis |
Dimeticone | Defoamer for surfactant poisoning | SurfactantsSurfactant-containing hand rinses, shampoos and similar products. |
Dimercaptopropane sulfonic acid (DMPS) | Chelating agent | Heavy metalsArsenic, bismuth, lead, chromium, copper, mercury. |
Iron(III) hexacyanoferrate (Berlin blue) | Binds thallium in the intestine | Thallium |
Flumazenil | GABA receptor antagonist | Benzodiazepine |
Fomepizole | Inhibits alcohol dehydrogenase |
Alcohol, diethylene glycol, ethylene glycol intoxicationCoolant freeze (hemodialysis here if necessary).
NoteIn alcohol withdrawal syndrome (AES): delirium prophylaxis should be started before hospital admission, if necessary. |
Hydroxocobalamin | Complexation of cyanide and cobalt | Alternative to 4-DMAP |
Methylene blue | Accelerates reduction of Met-Hb to Hb | Methemoglobinemia |
N-acetylcysteine | Inactivation of intermediate metabolites (e.g., N-acetyl-p-benzoquinoneimine). |
ParacetamolDichloroethane(meta-)acrylonitrileCarbon tetrachloride.
Single paracetamol overdose:
|
Naloxone | Opiate antagonist | Opioids, heroin/diacetylmorphine |
Sodium thiosulfate | Detoxification capacity ↑ | Hydrogen cyanide (bromates), cyanide, nitrile. |
Obidoxime | Reactivation of acetylcholinesterase by dephosphorylation. | Organophosphate intoxication (e.g., sarin). |
Penicillamine | Complexing agent | Lead, copper, mercury, zinc |
Physiostigmine, Neostigmine | Parasympathomimetic | AtropineIf necessary for severe GHB intoxication. |
Oxygen (100%) | Elimination of CO the higher the offered oxygen partial pressure (pO2) is |
Carbon monoxide poisoningNote:
|
Silibinin | Inhibits amatoxin uptake in the liver | Amatoxin, tuberous-leaved mushroom |
Toluidine blue (toluidine chloride) | Accelerates reduction of Met-Hb to Hb | Methemoglobin formers |
Vitamin K | Fat-soluble vitamin; cofactor of reactions of γ-glutamyl carboxylase | Phenprocoumon (Marcumar) |
4-dimethylaminophenol (4-DMAP) | Methemoglobin formation | Hydrogen cyanide, cyanide, nitrile, hydrogen sulfide. |
New therapeutic options
- Insulin – poisoning with beta blockers, calcium antagonists.
- Lipid emulsions – local anesthetic intoxication.
Antidota minimal equipment (“Bremen list”)
- Carbo medicinalis 50 g; administration only after consultation with the poison center.
- Atropine 100 mg ampoule; indication: organophosphate intoxication.
- 4-DMAP (dimethylaminophenol) 250 mg ampoule; indication: cyanidintoxication.
- Naloxone 0.4 mg ampoule; Indication: opioid intoxication.
- Toluidine blue 300 mg ampoule; indication: methemoglobin formers poisoning.